Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Contact
About us
Links
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Contact
About us
Links
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
About us
Contact
Links
About us
Contact
Links
Accordion Title
Accordion Content
more items +
Consumer confidence sinks to 8-month low on worries about inflation and Trump tariffs
Fed’s Logan backs shortening maturity of central bank’s balance sheet
This momentum-stock fund can lower your risk. It has outperformed the S&P 500.
Tesla sales slid by nearly 50% across Europe at the start of 2025
Looking forward to the great wealth transfer? Expect an $84 trillion mess instead.
Krispy Kreme stock heads for record low as earnings set for further disappointment
Eli Lilly cuts price of weight-loss drug Zepbound for self-paying patients
Planet Fitness shares stumble as outlook points to slower earnings growth
Novo Nordisk’s stock is rallying as Hims & Hers’ stock falters. An Ozempic alternative won’t be available for long.
There are dot-com echoes beyond tech. This Costco shareholder explains why returns will be paltry at best.
No ‘golden age’ is coming. Trump’s tariffs will hit Americans with higher interest rates and more inflation.
Home Depot’s stock falls as customers are showing caution on large remodels
Consumer confidence sinks to 8-month low on worries about inflation and Trump tariffs
Fed’s Logan backs shortening maturity of central bank’s balance sheet
This momentum-stock fund can lower your risk. It has outperformed the S&P 500.
Tesla sales slid by nearly 50% across Europe at the start of 2025
Looking forward to the great wealth transfer? Expect an $84 trillion mess instead.
Krispy Kreme stock heads for record low as earnings set for further disappointment
Eli Lilly cuts price of weight-loss drug Zepbound for self-paying patients
Planet Fitness shares stumble as outlook points to slower earnings growth
Novo Nordisk’s stock is rallying as Hims & Hers’ stock falters. An Ozempic alternative won’t be available for long.
There are dot-com echoes beyond tech. This Costco shareholder explains why returns will be paltry at best.
No ‘golden age’ is coming. Trump’s tariffs will hit Americans with higher interest rates and more inflation.
Home Depot’s stock falls as customers are showing caution on large remodels
Treasury yields drop to 10-week low as growth concerns build
25-02-25
Post Content
Share this on:
